Taylor Hooton Foundation > Hoot’s Corner > General > Anabolic steroid use drives hypogonadism in young men
June 17, 2013
Anabolic steroid use drives hypogonadism in young men
Another medical study has confirmed what many of us already know, that the use of anabolic steroids can lead to hypogonadism, even profound hypogonadism, in young males.  This negative symptom is one of the more common side effects of the use of these drugs.

What is “hypogonadism”?

Hypogonadism is a medical term which describes a diminished functional activity of the gonads – the testes and ovaries in males and females, respectively – that may result in diminished sex hormone biosynthesis and impaired gamete production and/or regulation. In layman’s terms, it is sometimes called “interrupted stage 1 puberty”. Low androgen (e.g., testosterone) levels are referred to as hypoandrogenism and low estrogen (e.g., estradiol) as hypoestrogenism, and may occur as symptoms of hypogonadism in both sexes, but are generally only diagnosed in males and females respectively.  Spermatogenesis and ovulation in males and females, respectively, may be impaired by hypogonadism, which, depending on the degree of severity, may result in partial or complete infertility.

For the medical community, these findings suggest that they need to refocus their approach to the diagnosis and treatment of this malady in hypogonadal young men. A summary of the latest study which was published in the Journal of Urology can be found here:  http://www.jurology.com/article/S0022-5347%2813%2904580-1/abstract